Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies - Concepedia

Concepedia

Publication | Open Access

Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies

DOI Full Paper Access

39

Citations

22

References

2021

Year

Mike Wenzel, Benedikt Hoeh, Maria Schroeder, Christoph Würnschimmel, Thomas Steuber, Hans Heinzer, Séverine Banek, Marit Ahrens, Andreas Becker, Pierre I. Karakiewicz,

Frontiers in Oncology

Abstract

Patients with TTCR <12 months are at the highest OS disadvantage in mHSPC. This OS disadvantage persisted even after multivariable adjustment. Interestingly, TTCR stratified analyses did not influence OS in mCRPC patients.

References

	Year	Citations

Page 1